The growing epidemic of HPV-positive oropharyngeal carcinoma: A clinical review for primary care providers

Kevin A. Moore, Vikas Mehta

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

While the rate of head and neck cancer has decreased in recent decades, the prevalence of oropharynx cancer has dramatically increased due to human papillomavirus (HPV)-related oropharyngeal cancer. Three of 4 newly diagnosed oropharyngeal carcinomas are HPV-positive, and by 2020 it is projected that the prevalence of this disease will overtake that of HPV-related cervical cancer. Recognized in recent years as a malignant entity distinct from HPV-negative oropharyngeal carcinoma, HPV-positive oropharyngeal cancer is associated with younger age at diagnosis, oral sexual behavior as a primary risk factor, nonspecific presentation, and improved treatment response compared with HPV-negative disease. Early recognition and referral for definitive treatment are paramount in decreasing morbidity and mortality, as well as improving the quality of life of these patients. Primary care providers are in an ideal position to improve patient outcomes through early recognition and referral, as well as coordination of comprehensive care of patients with this potentially devastating disease. Awareness of risk factors, a high index of suspicion, counseling patients and parents on the importance of vaccination against HPV, and coordinated care between primary care providers and specialists are vital to achieving improved outcomes for patients with this increasingly prevalent cancer.

Original languageEnglish (US)
Pages (from-to)498-503
Number of pages6
JournalJournal of the American Board of Family Medicine
Volume28
Issue number4
DOIs
StatePublished - Jul 1 2015
Externally publishedYes

Fingerprint

Primary Health Care
Carcinoma
Oropharyngeal Neoplasms
Referral and Consultation
Oral Diagnosis
Head and Neck Neoplasms
Uterine Cervical Neoplasms
Sexual Behavior
Counseling
Patient Care
Vaccination
Parents
Quality of Life
Morbidity
Mortality
Therapeutics
Neoplasms

Keywords

  • Cancer
  • Epidemiology
  • Head and neck cancer
  • Human papillomavirus
  • Oropharyngeal cancer
  • Otolaryngology

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

The growing epidemic of HPV-positive oropharyngeal carcinoma : A clinical review for primary care providers. / Moore, Kevin A.; Mehta, Vikas.

In: Journal of the American Board of Family Medicine, Vol. 28, No. 4, 01.07.2015, p. 498-503.

Research output: Contribution to journalReview article

@article{695484097bab4976bffbe756f0425b36,
title = "The growing epidemic of HPV-positive oropharyngeal carcinoma: A clinical review for primary care providers",
abstract = "While the rate of head and neck cancer has decreased in recent decades, the prevalence of oropharynx cancer has dramatically increased due to human papillomavirus (HPV)-related oropharyngeal cancer. Three of 4 newly diagnosed oropharyngeal carcinomas are HPV-positive, and by 2020 it is projected that the prevalence of this disease will overtake that of HPV-related cervical cancer. Recognized in recent years as a malignant entity distinct from HPV-negative oropharyngeal carcinoma, HPV-positive oropharyngeal cancer is associated with younger age at diagnosis, oral sexual behavior as a primary risk factor, nonspecific presentation, and improved treatment response compared with HPV-negative disease. Early recognition and referral for definitive treatment are paramount in decreasing morbidity and mortality, as well as improving the quality of life of these patients. Primary care providers are in an ideal position to improve patient outcomes through early recognition and referral, as well as coordination of comprehensive care of patients with this potentially devastating disease. Awareness of risk factors, a high index of suspicion, counseling patients and parents on the importance of vaccination against HPV, and coordinated care between primary care providers and specialists are vital to achieving improved outcomes for patients with this increasingly prevalent cancer.",
keywords = "Cancer, Epidemiology, Head and neck cancer, Human papillomavirus, Oropharyngeal cancer, Otolaryngology",
author = "Moore, {Kevin A.} and Vikas Mehta",
year = "2015",
month = "7",
day = "1",
doi = "10.3122/jabfm.2015.04.140301",
language = "English (US)",
volume = "28",
pages = "498--503",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "4",

}

TY - JOUR

T1 - The growing epidemic of HPV-positive oropharyngeal carcinoma

T2 - A clinical review for primary care providers

AU - Moore, Kevin A.

AU - Mehta, Vikas

PY - 2015/7/1

Y1 - 2015/7/1

N2 - While the rate of head and neck cancer has decreased in recent decades, the prevalence of oropharynx cancer has dramatically increased due to human papillomavirus (HPV)-related oropharyngeal cancer. Three of 4 newly diagnosed oropharyngeal carcinomas are HPV-positive, and by 2020 it is projected that the prevalence of this disease will overtake that of HPV-related cervical cancer. Recognized in recent years as a malignant entity distinct from HPV-negative oropharyngeal carcinoma, HPV-positive oropharyngeal cancer is associated with younger age at diagnosis, oral sexual behavior as a primary risk factor, nonspecific presentation, and improved treatment response compared with HPV-negative disease. Early recognition and referral for definitive treatment are paramount in decreasing morbidity and mortality, as well as improving the quality of life of these patients. Primary care providers are in an ideal position to improve patient outcomes through early recognition and referral, as well as coordination of comprehensive care of patients with this potentially devastating disease. Awareness of risk factors, a high index of suspicion, counseling patients and parents on the importance of vaccination against HPV, and coordinated care between primary care providers and specialists are vital to achieving improved outcomes for patients with this increasingly prevalent cancer.

AB - While the rate of head and neck cancer has decreased in recent decades, the prevalence of oropharynx cancer has dramatically increased due to human papillomavirus (HPV)-related oropharyngeal cancer. Three of 4 newly diagnosed oropharyngeal carcinomas are HPV-positive, and by 2020 it is projected that the prevalence of this disease will overtake that of HPV-related cervical cancer. Recognized in recent years as a malignant entity distinct from HPV-negative oropharyngeal carcinoma, HPV-positive oropharyngeal cancer is associated with younger age at diagnosis, oral sexual behavior as a primary risk factor, nonspecific presentation, and improved treatment response compared with HPV-negative disease. Early recognition and referral for definitive treatment are paramount in decreasing morbidity and mortality, as well as improving the quality of life of these patients. Primary care providers are in an ideal position to improve patient outcomes through early recognition and referral, as well as coordination of comprehensive care of patients with this potentially devastating disease. Awareness of risk factors, a high index of suspicion, counseling patients and parents on the importance of vaccination against HPV, and coordinated care between primary care providers and specialists are vital to achieving improved outcomes for patients with this increasingly prevalent cancer.

KW - Cancer

KW - Epidemiology

KW - Head and neck cancer

KW - Human papillomavirus

KW - Oropharyngeal cancer

KW - Otolaryngology

UR - http://www.scopus.com/inward/record.url?scp=84937131136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937131136&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2015.04.140301

DO - 10.3122/jabfm.2015.04.140301

M3 - Review article

C2 - 26152442

AN - SCOPUS:84937131136

VL - 28

SP - 498

EP - 503

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 4

ER -